Comment from BPIA
BPIASupportAdvocacy
Summary: The Biological Products Industry Alliance (BPIA), representing over 180 member companies, supports the USDA's request for information to modernize the regulatory framework for modified organisms. They argue for a science-based, risk-proportionate pathway that provides clear commercialization endpoints and reduces duplicative oversight for microbial products.
See attached file(s)